Cell Therapy Media Market

Cell Culture Consumables and Cell Culture Media Market (2nd Edition): Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Product (Culture Media, Kits, Cell Culture Reagents and Extracellular Matrices), Type of Cell Therapy (T-Cell Therapy, Stem Cell Therapy, Dendritic Cell Therapy and NK Cell Therapy), Scale of Operation (Clinical and Commercial), Type of End User (Industry and Non-Industry) and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa (MENA) and Latin America)

  • Lowest Price Guaranteed

  • Pages
    250

  • Last Updated
    July 2026

  • View Count
    19011

Table Of Contents

1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Context and Background
3.2. Introduction to Cell Therapies
3.3. Comparison of Cell Therapies with Other Biopharmaceuticals
3.4. Classification of Cell Therapy Products
3.5. Overview of Cell Therapy Development and Manufacturing
3.6. Role of Raw Materials in Cell Therapy Development and Manufacturing
3.7. Types of Cell Therapy Consumables
3.8. Key Challenges Associated with Manufacturing of Cell Therapy Consumables
3.9. Future Perspectives

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. List of Cell Therapy Kit Providers
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Location of Kit Manufacturing Facilities
4.2.5. Analysis by Certifications / Accreditations Received
4.2.6. Analysis by Type of End-User
4.2.7. Analysis by Type of Cell Therapy
4.2.8. Analysis by Type of Function
4.2.9. Analysis by Kit Components
4.2.10. Analysis by Storage Temperature
4.2.11. Analysis by Scale of Operation
4.2.12. Analysis by Application Area
4.2.13. Analysis by Application Area and Geography

4.3. List of Cell Therapy Media Providers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Analysis by Location of Media Manufacturing Facilities
4.3.5. Analysis by Certifications / Accreditations Received
4.3.6. Analysis by Type of End-User
4.3.7. Analysis by Type of Cell Therapy
4.3.8. Analysis by Media Compatibility
4.3.9. Analysis by Type of Function
4.3.10. Analysis by Storage Temperature
4.3.11. Analysis by Volume of Media
4.3.12. Analysis by Scale of Operation
4.3.13. Analysis by Application Area
4.3.14. Analysis by Application Area and Geography

4.4. List of Cell Therapy Reagent Providers
4.4.1. Analysis by Year of Establishment
4.4.2. Analysis by Company Size
4.4.3. Analysis by Location of Headquarters
4.4.4. Analysis by Location of Reagent Manufacturing Facilities
4.4.5. Analysis by Certifications / Accreditations Received
4.4.6. Analysis by Type of End-User
4.4.7. Analysis by Type of Cell Therapy
4.4.8. Analysis by Type of Function
4.4.9. Analysis by Storage Temperature
4.4.10. Analysis by Volume of Reagent
4.4.11. Analysis by Scale of Operation
4.4.12. Analysis by Application Area
4.4.13. Analysis by Application Area and Geography

4.5. List of Cell Therapy Extracellular Matrix Providers
4.5.1. Analysis by Year of Establishment
4.5.2. Analysis by Company Size
4.5.3. Analysis by Location of Headquarters
4.5.4. Analysis by Location of Extracellular Matrix Manufacturing Facilities
4.5.5. Analysis by Certifications / Accreditations Received
4.5.6. Analysis by Type of End-User
4.5.7. Analysis by Type of Stem Cell Therapy
4.5.8. Analysis by Type of Function
4.5.9. Analysis by Type of ECM Coating
4.5.10. Analysis by Type of Formulation
4.5.11. Analysis by Shelf Life
4.5.12. Analysis by Storage Temperature
4.5.13. Analysis by Volume of Extracellular Matrix
4.5.14. Analysis by Scale of Operation
4.5.15. Analysis by Application Area
4.5.16. Analysis by Application Area and Geography

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Key Assumptions and Parameters
5.3. Methodology
5.4. Cell Therapy Consumable Providers: Company Competitiveness Analysis
5.5. Cell Therapy Kits Providers
5.6. Cell Therapy Media Providers
5.6.1. Cell Therapy Media Providers based in North America
5.6.2. Cell Therapy Media Providers based in Europe
5.6.3. Cell Therapy Media Providers based in Asia-Pacific

5.7. Cell Therapy Reagent Providers
5.8. Cell Therapy Extracellular Matrix Providers

6. BRAND POSITIONING OF KEY INDUSTRY PLAYERS
6.1. Chapter Overview
6.2. Scope and Methodology
6.3. Brand Positioning: STEMCELL Technologies
6.4. Brand Positioning: Miltenyi Biotec
6.5. Brand Positioning: Thermo Fisher Scientific
6.6. Brand Positioning: Takara Bio
6.7. Brand Positioning: GeminiBio

7. COMPANY PROFILES
7.1. Chapter Overview
7.2. STEMCELL Technologies
7.2.1. Company Overview
7.2.2. Product Portfolio
7.2.3. Recent Developments and Future Outlook

7.3. Miltenyi Biotec
7.3.1. Company Overview
7.3.2. Product Portfolio
7.3.3. Recent Developments and Future Outlook

7.4. Thermo Fisher Scientific
7.4.1. Company Overview
7.4.2. Product Portfolio
7.4.3. Recent Developments and Future Outlook

7.5. Bio-Techne
7.5.1. Company Overview
7.5.2. Product Portfolio
7.5.3. Recent Developments and Future Outlook

7.6. Irvine Scientific
7.6.1. Company Overview
7.6.2. Product Portfolio
7.6.3. Recent Developments and Future Outlook

7.7. Lonza
7.7.1. Company Overview
7.7.2. Product Portfolio
7.7.3. Recent Developments and Future Outlook

7.8. Sartorius
7.8.1. Company Overview
7.8.2. Product Portfolio
7.8.3. Recent Developments and Future Outlook

7.9. BD Biosciences
7.9.1. Company Overview
7.9.2. Product Portfolio
7.9.3. Recent Developments and Future Outlook

7.10. Corning
7.10.1. Company Overview
7.10.2. Product Portfolio
7.10.3. Recent Developments and Future Outlook

7.11. CellGenix
7.11.1. Company Overview
7.11.2. Product Portfolio
7.11.3. Recent Developments and Future Outlook

8. RECENT DEVELOPMENTS AND INITIATIVES
8.1. Chapter Overview
8.2. Partnership Models

8.3. Cell Therapy Consumables: Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Year and Type of Partnership
8.3.4. Analysis by Type of Product
8.3.5. Analysis by Type of Partnership and Type of Product
8.3.6. Analysis by Type of Cell Therapy
8.3.7. Analysis by Type of Product and Type of Cell Therapy
8.3.8. Most Active Players: Analysis by Number of Partnerships
8.3.9. Analysis by Region
8.3.9.1. Intercontinental and Intracontinental Agreements
8.3.9.2. Local and International Agreements

8.4. Cell Therapy Consumables: Mergers and Acquisitions
8.4.1. Cumulative Year-wise Trend of Mergers and Acquisitions
8.4.2. Analysis by Type of Agreement
8.4.3. Analysis by Key Value Drivers
8.4.4. Analysis by Year of Acquisition and Key Value Drivers

8.5. Cell Therapy Consumables: Recent Expansions
8.5.1. Analysis by Year of Expansion
8.5.2. Analysis by Type of Expansion
8.5.3. Analysis by Year and Type of Expansion
8.5.4. Analysis by Type of Product
8.5.5. Analysis by Type of Expansion and Type of Product
8.5.6. Analysis by Area of Expansion
8.5.7. Most Active Players: Analysis by Number of Expansions
8.5.8. Analysis by Region
8.5.8.1. Analysis by Location of Facility (Continent-wise)
8.5.8.2. Analysis by Location of Facility (Country-wise)
8.5.9. Analysis by Type of Expansion and Location of Facility

9. LIKELY PARTNER ANALYSIS FOR CELL THERAPY CONSUMABLE PROVIDERS
9.1. Chapter Overview
9.2. Scoring Criteria and Key Assumptions
9.3. Scope and Methodology
9.4. Key Potential Strategic Partners for Cell Therapy Consumable Providers
9.4.1. Likely Partners for Dendritic Cell Therapy Consumable Providers
9.4.2. Likely Partners for NK Cell Therapy Consumable Providers
9.4.3. Likely Partners for Stem Cell Therapy Consumable Providers
9.4.4. Likely Partners for T-Cell Therapy Consumable Providers

10. ROOTS ANALYSIS PRICING STRATEGY
10.1. Chapter Overview
10.2. Roots Analysis Framework
10.2.1. Theoretical Framework and Price Evaluation Hypothesis for Cell Therapy Media
10.2.1.1. Methodology
10.2.1.2. Results and Interpretation
10.2.1.2.1. Cell Therapy Media Price Evaluation Matrix: Information on Volume of Media
10.2.1.2.2. Cell Therapy Media Price Evaluation Matrix: Information on Media Compatibility
10.2.1.2.3. Cell Therapy Media Price Evaluation Matrix: Information on Type of Product Manufacturing Practices
10.2.1.2.4. Cell Therapy Media Price Evaluation Matrix: Information on Application Area
10.2.1.2.5. Cell Therapy Media Price Evaluation Matrix: Information on Storage Temperature
10.2.1.2.6. Cell Therapy Media Price Evaluation Matrix: Information on Type of Cell Therapy
10.2.1.2.7. Cell Therapy Media Price Evaluation Matrix: Information on Type of Function
10.2.2. Theoretical Framework and Price Evaluation Hypothesis of Cell Therapy Extracellular Matrices
10.2.2.1. Methodology
10.2.2.2. Results and Interpretation
10.2.2.2.1. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Type of ECM Coating
10.2.2.2.2. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Type of Formulation
10.2.2.2.3. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Volume of Extracellular Matrices
10.2.2.2.4. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Storage Temperature
10.2.2.2.5. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Shelf Life
10.2.2.2.6. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Type of Stem Cell Therapy
10.2.2.2.7. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Type of Function

11. DEMAND ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Global Demand for Cell Therapy Consumables
11.3.1. Global Demand for Cell Therapy Consumables for Planar Processes
11.3.2. Global Demand for Cell Therapy Consumables for Suspension Processes
11.4. Analysis by Scale of Operation
11.5. Analysis by Geography

12. MARKET FORECAST AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Key Assumptions and Methodology
12.3. Global Cell Therapy Consumables Market, 2023-2035

12.4. Cell Therapy Consumables Market: Analysis by Type of Product
12.4.1. Cell Therapy Consumables Market for Extracellular Matrices, 2023-2035
12.4.2. Cell Therapy Consumables Market for Kits, 2023-2035
12.4.3. Cell Therapy Consumables Market for Media, 2023-2035
12.4.4. Cell Therapy Consumables Market for Reagents, 2023-2035

12.5. Cell Therapy Consumables Market: Analysis by Type of Cell Therapy
12.5.1. Cell Therapy Consumables Market for Dendritic Cell Therapies, 2023-2035
12.5.2. Cell Therapy Consumables Market for NK Cell Therapies, 2023-2035
12.5.3. Cell Therapy Consumables Market for Stem Cell Therapies, 2023-2035
12.5.4. Cell Therapy Consumables Market for T-Cell Therapies, 2023-2035

12.6. Cell Therapy Consumables Market: Analysis by Scale of Operation
12.6.1. Cell Therapy Consumables Market for Clinical Operations, 2023-2035
12.6.2. Cell Therapy Consumables Market for Commercial Operations, 2023-2035

12.7. Cell Therapy Consumables Market: Analysis by Type of End-User
12.7.1. Cell Therapy Consumables Market for Industry Players, 2023-2035
12.7.2. Cell Therapy Consumables Market for Non-Industry Players, 2023-2035

12.8. Cell Therapy Consumables Market: Analysis by Geography
12.8.1. Cell Therapy Consumables Market in North America, 2023-2035
12.8.1.1. Cell Therapy Consumables Market in the US, 2023-2035
12.8.1.2. Cell Therapy Consumables Market in Canada, 2023-2035
12.8.1.3. Cell Therapy Consumables Market in Rest of North America, 2023-2035

12.8.2. Cell Therapy Consumables Market in Europe, 2023-2035
12.8.2.1. Cell Therapy Consumables Market in Spain, 2023-2035
12.8.2.2. Cell Therapy Consumables Market in France, 2023-2035
12.8.2.3. Cell Therapy Consumables Market in Germany, 2023-2035
12.8.2.4. Cell Therapy Consumables Market in Italy, 2023-2035
12.8.2.5. Cell Therapy Consumables Market in the Netherlands, 2023-2035
12.8.2.6. Cell Therapy Consumables Market in the UK, 2023-2035
12.8.2.7. Cell Therapy Consumables Market in Rest of Europe, 2023-2035

12.8.3. Cell Therapy Consumables Market in Asia-Pacific, 2023-2035
12.8.3.1. Cell Therapy Consumables Market in China, 2023-2035
12.8.3.2. Cell Therapy Consumables Market in Korea, 2023-2035
12.8.3.3. Cell Therapy Consumables Market in Rest of Asia-Pacific, 2023-2035

12.8.4. Cell Therapy Consumables Market in Middle East and North Africa, 2023-2035
12.8.5. Cell Therapy Consumables Market in Latin America, 2023-2035

13. UPCOMING TRENDS AND FUTURE GROWTH OPPORTUNITIES
13.1. Chapter Overview
13.2. Emerging Trends Related to Cell Culture Media
13.3. Automation of Cell Therapy Manufacturing Processes
13.4. Single Use Systems and Technologies in Cell Therapy Manufacturing

14. CONCLUDING REMARKS

15. INTERVIEW TRANSCRIPTS
15.1. Chapter Overview
15.2. Akadeum Life Sciences
15.2.1. Interview Transcript: Michael Maloney, Vice President of Business Development - Cell Therapy

15.3. Cellular Engineering Technologies
15.3.1. Interview Transcript: Anant Kamath, Chief Operating Officer

15.4. HiMedia Laboratories
15.4.1. Interview Transcript: Vishal G. Warke, Director R&D, Cell Culture and Immunology and Gauri W. Page, Assistant R&D Manager, Animal Cell Culture

16. APPENDIX I: TABULATED DATA

17. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 2.1 Executive Summary: Market Landscape of Cell Therapy Consumable Providers
Figure 2.2 Executive Summary: Market Landscape of Cell Therapy Consumables
Figure 2.3 Executive Summary: Recent Developments and Initiatives
Figure 2.4 Executive Summary: Demand Analysis
Figure 2.5 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Types of Cell Therapy Consumables
Figure 4.1 Cell Therapy Consumables: Distribution by Type of Product
Figure 4.2 Cell Therapy Consumable Providers: Distribution by Company Size and Location of Headquarters 
Figure 4.3 Cell Therapy Kit Providers: Distribution by Year of Establishment
Figure 4.4 Cell Therapy Kit Providers: Distribution by Company Size
Figure 4.5 Cell Therapy Kit Providers: Distribution by Location of Headquarters
Figure 4.6 Cell Therapy Kit Providers: Distribution by Location of Kit Manufacturing Facilities
Figure 4.7 Cell Therapy Kit Providers: Distribution by Certifications / Accreditations Received
Figure 4.8 Cell Therapy Kit Providers: Distribution by Type of End-User
Figure 4.9 Cell Therapy Kits: Distribution by Type of Cell Therapy
Figure 4.10 Cell Therapy Kits: Distribution by Type of Function
Figure 4.11 Cell Therapy Kits: Distribution by Kit Components
Figure 4.12 Cell Therapy Kits: Distribution by Storage Temperature
Figure 4.13 Cell Therapy Kits: Distribution by Scale of Operation
Figure 4.14 Cell Therapy Kits: Distribution by Application Area
Figure 4.15 Cell Therapy Kit Providers: Distribution by Application Area and Geography
Figure 4.16 Cell Therapy Media Providers: Distribution by Year of Establishment
Figure 4.17 Cell Therapy Media Providers: Distribution by Company Size
Figure 4.18 Cell Therapy Media Providers: Distribution by Location of Headquarters
Figure 4.19 Cell Therapy Media Providers: Distribution by Location of Media Manufacturing Facilities
Figure 4.20 Cell Therapy Media Providers: Distribution by Certifications / Accreditations Received
Figure 4.21 Cell Therapy Media Providers: Distribution by Type of End-User
Figure 4.22 Cell Therapy Media: Distribution by Type of Cell Therapy
Figure 4.23 Cell Therapy Media: Distribution by Media Compatibility
Figure 4.24 Cell Therapy Media: Distribution by Type of Function
Figure 4.25 Cell Therapy Media: Distribution by Storage Temperature
Figure 4.26 Cell Therapy Media: Distribution by Volume of Media
Figure 4.27 Cell Therapy Media: Distribution by Scale of Operation
Figure 4.28 Cell Therapy Media: Distribution by Application Area
Figure 4.29 Cell Therapy Media Providers: Distribution by Application Area and Geography
Figure 4.30 Cell Therapy Reagent Providers: Distribution by Year of Establishment
Figure 4.31 Cell Therapy Reagent Providers: Distribution by Company Size
Figure 4.32 Cell Therapy Reagent Providers: Distribution by Location of Headquarters
Figure 4.33 Cell Therapy Reagent Providers: Distribution by Location of Reagent Manufacturing Facilities
Figure 4.34 Cell Therapy Reagent Providers: Distribution by Certifications / Accreditations Received
Figure 4.35 Cell Therapy Reagent Providers: Distribution by Type of End-User
Figure 4.36 Cell Therapy Reagents: Distribution by Type of Cell Therapy
Figure 4.37 Cell Therapy Reagents: Distribution by Type of Function
Figure 4.38 Cell Therapy Reagents: Distribution by Storage Temperature
Figure 4.39 Cell Therapy Reagents: Distribution by Volume of Reagent
Figure 4.40 Cell Therapy Reagents: Distribution by Scale of Operation
Figure 4.41 Cell Therapy Reagents: Distribution by Application Area
Figure 4.42 Cell Therapy Reagent Providers: Distribution by Application Area and Geography
Figure 4.43 Cell Therapy Extracellular Matrix Providers: Distribution by Year of Establishment
Figure 4.44 Cell Therapy Extracellular Matrix Providers: Distribution by Company Size
Figure 4.45 Cell Therapy Extracellular Matrix Providers: Distribution by Location of Headquarters
Figure 4.46 Cell Therapy Extracellular Matrix Providers: Distribution by Location of Extracellular Matrix Manufacturing Facilities
Figure 4.47 Cell Therapy Extracellular Matrix Providers: Distribution by Certifications / Accreditations Received
Figure 4.48 Cell Therapy Extracellular Matrix Providers: Distribution by Type of End-User
Figure 4.49 Cell Therapy Extracellular Matrices: Distribution by Type of Stem Cell Therapy
Figure 4.50 Cell Therapy Extracellular Matrices: Distribution by Type of Function
Figure 4.51 Cell Therapy Extracellular Matrices: Distribution by Type of ECM Coating
Figure 4.52 Cell Therapy Extracellular Matrices: Distribution by Type of Formulation
Figure 4.53 Cell Therapy Extracellular Matrices: Distribution by Shelf Life
Figure 4.54 Cell Therapy Extracellular Matrices: Distribution by Storage Temperature
Figure 4.55 Cell Therapy Extracellular Matrices: Distribution by Volume of Extracellular Matrix
Figure 4.56 Cell Therapy Extracellular Matrices: Distribution by Scale of Operation
Figure 4.57 Cell Therapy Extracellular Matrices: Distribution by Application Area
Figure 4.58 Cell Therapy Extracellular Matrix Providers: Distribution by Application Area and Geography
Figure 5.1 Company Competitiveness Analysis: Cell Therapy Kit Providers
Figure 5.2 Company Competitiveness Analysis: Cell Therapy Media Providers based in North America
Figure 5.3 Company Competitiveness Analysis: Cell Therapy Media Providers based in Europe
Figure 5.4 Company Competitiveness Analysis: Cell Therapy Media Providers based in Asia-Pacific 
Figure 5.5 Company Competitiveness Analysis: Cell Therapy Reagent Providers
Figure 5.6 Company Competitiveness Analysis: Cell Therapy Extracellular Matrix Providers
Figure 6.1 Brand Positioning Matrix: STEMCELL Technologies
Figure 6.2 Brand Positioning Matrix: Miltenyi Biotec  
Figure 6.3 Brand Positioning Matrix: Thermo Fisher Scientific
Figure 6.4 Brand Positioning Matrix: Takara Bio
Figure 6.5 Brand Positioning Matrix: GeminiBio
Figure 7.1 STEMCELL Technologies: Product Portfolio
Figure 7.2 Miltenyi Biotec: Product Portfolio
Figure 7.3 Thermo Fisher Scientific: Product Portfolio
Figure 7.4 Bio-Techne: Product Portfolio
Figure 7.5 Irvine Scientific: Product Portfolio
Figure 7.6 Lonza: Product Portfolio
Figure 7.7 Sartorius: Product Portfolio
Figure 7.8 BD Biosciences: Product Portfolio
Figure 7.9 Corning: Product Portfolio
Figure 7.10 CellGenix: Product Portfolio
Figure 8.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2015-2022
Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 8.4 Partnerships and Collaborations: Distribution by Type of Product
Figure 8.5 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Consumable
Figure 8.6 Partnerships and Collaborations: Distribution by Type of Cell Therapy
Figure 8.7 Partnerships and Collaborations: Distribution by Type of Product and Type of Cell Therapy
Figure 8.8 Most Active Players: Distribution by Number of Partnerships
Figure 8.9 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 8.10 Partnerships and Collaborations: Local and International Agreements
Figure 8.11 Mergers and Acquisitions: Cumulative Year-wise Trend, 2016-2022
Figure 8.12 Mergers and Acquisitions: Distribution by Type of Agreement
Figure 8.13 Mergers and Acquisitions: Distribution by Key Value Drivers
Figure 8.14 Mergers and Acquisitions: Distribution by Year of Acquisition and Key Value Drivers
Figure 8.15 Recent Expansions: Cumulative Year-wise Trend, 2017-2022
Figure 8.16 Recent Expansions: Distribution by Type of Expansion
Figure 8.17 Recent Expansions: Distribution by Year and Type of Expansion
Figure 8.18 Recent Expansions: Distribution by Type of Product
Figure 8.19 Recent Expansions: Distribution by Type of Expansion and Type of Product
Figure 8.20 Recent Expansions: Distribution by Area of Expansion (Sq. Ft.)
Figure 8.21 Most Active Players: Distribution by Number of Expansions
Figure 8.22 Recent Expansions: Distribution by Location of Facility (Continent-wise)
Figure 8.23 Recent Expansions: Distribution by Location of Facility (Country-wise)
Figure 8.24 Recent Expansions: Distribution by Type of Expansion and Location of Facility
Figure 10.1 Cell Therapy Media: Roots Analysis Pricing Strategy Graphical Representation
Figure 10.2 Cell Therapy Extracellular Matrices: Roots Analysis Pricing Strategy Graphical Interpretation
Figure 11.1 Global Demand for Cell Therapy Consumables for Planar Process, 2023-2035 (Million Liters)
Figure 11.2 Global Demand for Cell Therapy Consumables for Suspension Process, 2023-2035 (Million Liters)
Figure 11.3 Global Demand for Cell Therapy Consumables for Planar Process, 2023-2035: Distribution by Scale of Operation (Million Liters)
Figure 11.4 Global Demand for Cell Therapy Consumables for Suspension Process, 2023-2035: Distribution by Scale of Operation (Million Liters)
Figure 11.5 Global Demand for Cell Therapy Consumables: Distribution by Geography, 2023 and 2035
Figure 11.6 Global Demand for Cell Therapy Consumables for Planar Process, 2023-2035: Distribution by Geography (Million Liters)
Figure 11.7 Global Demand for Cell Therapy Consumables for Suspension Process, 2023-2035: Distribution by Geography (Million Liters)
Figure 12.1 Global Cell Therapy Consumables Market, 2023-2035 (USD Million)
Figure 12.2 Cell Therapy Consumables Market: Distribution by Type of Product, 2023 and 2035
Figure 12.3 Cell Therapy Consumables Market for Extracellular Matrices, 2023-2035 (USD Million)
Figure 12.4 Cell Therapy Consumables Market for Kits, 2023-2035 (USD Million)
Figure 12.5 Cell Therapy Consumables Market for Media, 2023-2035 (USD Million)
Figure 12.6 Cell Therapy Consumables Market for Reagents, 2023-2035 (USD Million)
Figure 12.7 Cell Therapy Consumables Market: Distribution by Type of Cell Therapy, 2023, 2028 and 2035
Figure 12.8 Cell Therapy Consumables Market for Dendritic Cell Therapies, 2023-2035 (USD Million)
Figure 12.9 Cell Therapy Consumables Market for NK Cell Therapies, 2023-2035 (USD Million)
Figure 12.10 Cell Therapy Consumables Market for Stem Cell Therapies, 2023-2035 (USD Million)
Figure 12.11 Cell Therapy Consumables Market for T-Cell Therapies, 2023-2035 (USD Million)
Figure 12.12 Cell Therapy Consumables Market: Distribution by Scale of Operation, 2023 and 2035
Figure 12.13 Cell Therapy Consumables Market for Clinical Operations, 2023-2035 (USD Million)
Figure 12.14 Cell Therapy Consumables Market for Commercial Operations, 2023-2035 (USD Million)
Figure 12.15 Cell Therapy Consumables Market: Distribution by Type of End-User, 2023 and 2035
Figure 12.16 Cell Therapy Consumables Market for Industry Players, 2023-2035 (USD Million)
Figure 12.17 Cell Therapy Consumables Market for Non-Industry Players, 2023-2035 (USD Million)
Figure 12.18 Cell Therapy Consumables Market: Distribution by Geography, 2023 and 2035
Figure 12.19 Cell Therapy Consumables Market in North America, 2023-2035 (USD Million)
Figure 12.20 Cell Therapy Consumables Market in the US, 2023-2035 (USD Million)
Figure 12.21 Cell Therapy Consumables Market in Canada, 2023-2035 (USD Million)
Figure 12.22 Cell Therapy Consumables Market in Rest of North America, 2023-2035 (USD Million)
Figure 12.23 Cell Therapy Consumables Market in Europe, 2023-2035 (USD Million)
Figure 12.24 Cell Therapy Consumables Market in Spain, 2023-2035 (USD Million)
Figure 12.25 Cell Therapy Consumables Market in France, 2023-2035 (USD Million)
Figure 12.26 Cell Therapy Consumables Market in Germany, 2023-2035 (USD Million)
Figure 12.27 Cell Therapy Consumables Market in the UK, 2023-2035 (USD Million)
Figure 12.28 Cell Therapy Consumables Market in Italy, 2023-2035 (USD Million)
Figure 12.29 Cell Therapy Consumables Market in Netherlands, 2023-2035 (USD Million)
Figure 12.30 Cell Therapy Consumables Market in Rest of Europe, 2023-2035 (USD Million)
Figure 12.31 Cell Therapy Consumables Market in Asia-Pacific, 2023-2035 (USD Million)
Figure 12.32 Cell Therapy Consumables Market in China, 2023-2035 (USD Million)
Figure 12.33 Cell Therapy Consumables Market in Japan, 2023-2035 (USD Million)
Figure 12.34 Cell Therapy Consumables Market in Rest of Asia-Pacific, 2023-2035 (USD Million)
Figure 12.35 Cell Therapy Consumables Market in Middle East and North Africa, 2023-2035 (USD Million)
Figure 12.36 Cell Therapy Consumables Market in Latin America, 2023-2035 (USD Million)
Figure 14.1 Concluding Remarks: Market Overview of Cell Therapy Kits
Figure 14.2 Concluding Remarks: Market Overview of Cell Therapy Media
Figure 14.3 Concluding Remarks: Market Overview of Cell Therapy Reagents
Figure 14.4 Concluding Remarks: Market Overview of Cell Therapy Extracellular Matrices
Figure 14.5 Concluding Remarks: Recent Developments and Initiatives
Figure 14.6 Concluding Remarks: Demand Analysis
Figure 14.7 Concluding Remarks: Market Forecast and Opportunity Analysis (I/II)
Figure 14.8 Concluding Remarks: Market Forecast and Opportunity Analysis (II/II)

List Of Tables

Table 3.1 Cell Therapies: Applications
Table 3.2 Differences between Cell Therapies and Other Biopharmaceuticals
Table 3.3 Key Cell Therapy Manufacturing Steps
Table 3.4 Types of Media Used in Cell Therapy Manufacturing
Table 4.1 List of Cell Therapy Kit Providers
Table 4.2 Cell Therapy Kits: Information on Type of Cell Therapy and Type of Function
Table 4.3 Cell Therapy Kits: Information on Kit Components and Storage Temperature
Table 4.4 Cell Therapy Kits: Information on Scale of Operation and Application Area
Table 4.5 List of Cell Therapy Media Providers
Table 4.6 Cell Therapy Media: Information on Type of Cell Therapy, Media Compatibility and Type of Function
Table 4.7 Cell Therapy Media: Information on Storage Temperature and Volume of Media
Table 4.8 Cell Therapy Media: Information on Scale of Operation and Application Area
Table 4.9 List of Cell Therapy Reagent Providers
Table 4.10 Cell Therapy Reagents: Information on Type of Cell Therapy and Type of Function
Table 4.11 Cell Therapy Reagents: Information on Storage Temperature and Volume of Reagent
Table 4.12 Cell Therapy Reagents: Information on Scale of Operation and Application Area
Table 4.13 List of Cell Therapy Extracellular Matrix Providers
Table 4.14 Cell Therapy Extracellular Matrices: Information on Type of Stem Cell Therapy and Type of Function
Table 4.15 Cell Therapy Extracellular Matrices: Information on Type of ECM Coating and Type of Formulation
Table 4.16 Cell Therapy Extracellular Matrices: Information on Shelf Life, Storage Temperature and Volume of Extracellular Matrix
Table 4.17 Cell Therapy Extracellular Matrices: Information on Scale of Operation and Application Area
Table 5.1 Company Competitiveness Analysis: Information on Peer Groups
Table 7.1 List of Leading Cell Therapy Consumable Providers
Table 7.2 STEMCELL Technologies: Company Overview
Table 7.3 STEMCELL Technologies: Recent Developments and Future Outlook
Table 7.4 Miltenyi Biotec: Company Overview
Table 7.5 Miltenyi Biotec: Recent Developments and Future Outlook
Table 7.6 Thermo Fisher Scientific: Company Overview
Table 7.7 Thermo Fisher Scientific: Recent Developments and Future Outlook
Table 7.8 Bio-Techne: Company Overview
Table 7.9 Bio-Techne: Recent Developments and Future Outlook
Table 7.10 Irvine Scientific: Company Overview
Table 7.11 Irvine Scientific: Recent Developments and Future Outlook
Table 7.12 Lonza: Company Overview
Table 7.13 Sartorius: Company Overview
Table 7.14 Sartorius: Recent Developments and Future Outlook
Table 7.15 BD Biosciences: Company Overview
Table 7.16 BD Biosciences: Recent Developments and Future Outlook
Table 7.17 Corning: Company Overview
Table 7.18 CellGenix: Company Overview
Table 7.19 CellGenix: Recent Developments and Future Outlook
Table 8.1 Cell Therapy Consumables: List of Partnerships and Collaborations, 2015-2022
Table 8.2 Cell Therapy Consumables: Information on Location of Headquarters, 2015-2022
Table 8.3 Mergers and Acquisitions: List of Mergers and Acquisitions, 2016-2022
Table 8.4 Mergers and Acquisitions: Information on Key Value Drivers, 2016-2022
Table 8.5 Cell Therapy Consumables: List of Recent Expansions, 2017-2022
Table 9.1 Likely Partners for Dendritic Cell Therapy Consumable Providers
Table 9.2 Likely Partners for NK Cell Therapy Consumable Providers
Table 9.3 Likely Partners for Stem Cell Therapy Consumable Providers
Table 9.4 Likely Partners for T-Cell Therapy Consumable Providers
Table 10.1 Cell Therapy Media Price Evaluation Matrix: Based on Volume of Media (USD)
Table 10.2 Cell Therapy Media Price Evaluation Matrix: Based on Media Compatibility (USD)
Table 10.3 Cell Therapy Media Price Evaluation Matrix: Based on Type of Product Manufacturing Practices (USD)
Table 10.4 Cell Therapy Media Price Evaluation Matrix: Based on Application Area (USD)
Table 10.5 Cell Therapy Media Price Evaluation Matrix: Based on Storage Temperature (USD)
Table 10.6 Cell Therapy Media Price Evaluation Matrix: Based on Type of Cell Therapy (USD)
Table 10.7 Cell Therapy Media Price Evaluation Matrix: Based on Type of Function (USD)
Table 10.8 Cell Therapy Extracellular Matrices Price Evaluation Matrix: Based on Type of ECM Coating (USD)
Table 10.9 Cell Therapy Extracellular Matrices Price Evaluation Matrix: Based on Type of Formulation (USD)
Table 10.10 Cell Therapy Extracellular Matrices Price Evaluation Matrix: Based on Volume of Extracellular Matrix (USD)
Table 10.11 Cell Therapy Extracellular Matrices Price Evaluation Matrix: Based on Storage Temperature (USD)
Table 10.12 Cell Therapy Extracellular Matrices Price Evaluation Matrix: Based on Shelf Life (USD)
Table 10.13 Cell Therapy Extracellular Matrices Price Evaluation Matrix: Based on Type of Stem Cell Therapy (USD)
Table 10.14 Cell Therapy Extracellular Matrices Price Evaluation Matrix: Based on Type of Function (USD)
Table 15.1 Akadeum Life Sciences: Key Highlights
Table 15.2 Cellular Engineering Technologies: Key Highlights
Table 15.3 HiMedia Laboratories: Key Highlights
Table 16.1 Cell Therapy Consumables: Distribution by Type of Product
Table 16.2 Cell Therapy Consumable Providers: Distribution by Company Size and Location of Headquarters
Table 16.3 Cell Therapy Kit Providers: Distribution by Year of Establishment
Table 16.4 Cell Therapy Kit Providers: Distribution by Company Size
Table 16.5 Cell Therapy Kit Providers: Distribution by Location of Headquarters
Table 16.6 Cell Therapy Kit Providers: Distribution by Location of Kit Manufacturing Facilities
Table 16.7 Cell Therapy Kit Providers: Distribution by Certifications / Accreditations Received
Table 16.8 Cell Therapy Kit Providers: Distribution by Type of End-User
Table 16.9 Cell Therapy Kits: Distribution by Type of Cell Therapy
Table 16.10 Cell Therapy Kits: Distribution by Type of Function
Table 16.11 Cell Therapy Kits: Distribution by Kit Components
Table 16.12 Cell Therapy Kits: Distribution by Storage Temperature
Table 16.13 Cell Therapy Kits: Distribution by Scale of Operation
Table 16.14 Cell Therapy Kits: Distribution by Application Area
Table 16.15 Cell Therapy Media Providers: Distribution by Year of Establishment
Table 16.16 Cell Therapy Media Providers: Distribution by Company Size
Table 16.17 Cell Therapy Media Providers: Distribution by Location of Headquarters
Table 16.18 Cell Therapy Media Providers: Distribution by Location of Media Manufacturing Facilities
Table 16.19 Cell Therapy Media Providers: Distribution by Certifications / Accreditations Received
Table 16.20 Cell Therapy Media Providers: Distribution by Type of End-User
Table 16.21 Cell Therapy Media: Distribution by Type of Cell Therapy
Table 16.22 Cell Therapy Media: Distribution by Media Compatibility
Table 16.23 Cell Therapy Media: Distribution by Type of Function
Table 16.24 Cell Therapy Media: Distribution by Storage Temperature
Table 16.25 Cell Therapy Media: Distribution by Volume of Media
Table 16.26 Cell Therapy Media: Distribution by Scale of Operation
Table 16.27 Cell Therapy Media: Distribution by Application Area
Table 16.28 Cell Therapy Reagent Providers: Distribution by Year of Establishment
Table 16.29 Cell Therapy Reagent Providers: Distribution by Company Size
Table 16.30 Cell Therapy Reagent Providers: Distribution by Location of Headquarters
Table 16.31 Cell Therapy Reagent Providers: Distribution by Location of Reagent Manufacturing Facilities
Table 16.32 Cell Therapy Reagent Providers: Distribution by Certifications / Accreditations Received
Table 16.33 Cell Therapy Reagent Providers: Distribution by Type of End-User
Table 16.34 Cell Therapy Reagents: Distribution by Type of Cell Therapy
Table 16.35 Cell Therapy Reagents: Distribution by Type of Function
Table 16.36 Cell Therapy Reagents: Distribution by Storage Temperature
Table 16.37 Cell Therapy Reagents: Distribution by Volume of Reagent
Table 16.38 Cell Therapy Reagents: Distribution by Scale of Operation
Table 16.39 Cell Therapy Reagents: Distribution by Application Area
Table 16.40 Cell Therapy Extracellular Matrix Providers: Distribution by Year of Establishment
Table 16.41 Cell Therapy Extracellular Matrix Providers: Distribution by Company Size
Table 16.42 Cell Therapy Extracellular Matrix Providers: Distribution by Location of Headquarters
Table 16.43 Cell Therapy Extracellular Matrix Providers: Distribution by Location of Extracellular Matrix Manufacturing Facilities
Table 16.44 Cell Therapy Extracellular Matrix Providers: Distribution by Certifications / Accreditations Received
Table 16.45 Cell Therapy Extracellular Matrix Providers: Distribution by Type of End-User
Table 16.46 Cell Therapy Extracellular Matrices: Distribution by Type of Stem Cell Therapy
Table 16.47 Cell Therapy Extracellular Matrices: Distribution by Type of Function
Table 16.48 Cell Therapy Extracellular Matrices: Distribution by Type of ECM Coating
Table 16.49 Cell Therapy Extracellular Matrices: Distribution by Type of Formulation
Table 16.50 Cell Therapy Extracellular Matrices: Distribution by Shelf Life
Table 16.51 Cell Therapy Extracellular Matrices: Distribution by Storage Temperature
Table 16.52 Cell Therapy Extracellular Matrices: Distribution by Volume of Extracellular Matrix
Table 16.53 Cell Therapy Extracellular Matrices: Distribution by Scale of Operation
Table 16.54 Cell Therapy Extracellular Matrices: Distribution by Application Area
Table 16.55 Partnerships and Collaborations: Cumulative Year-wise Trend, 2015-2022
Table 16.56 Partnerships and Collaborations: Distribution by Type of Partnership
Table 16.57 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partnership, 2015-2022
Table 16.58 Partnerships and Collaborations: Distribution by Type of Product
Table 16.59 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Product
Table 16.60 Partnerships and Collaborations: Distribution by Type of Cell Therapy
Table 16.61 Partnerships and Collaborations: Distribution by Type of Product and Type of Cell Therapy
Table 16.62 Most Active Players: Distribution by Number of Partnerships
Table 16.63 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 16.64 Partnerships and Collaborations: Local and International Agreements
Table 16.65 Mergers and Acquisitions: Cumulative Year-wise Trend, 2016-2022
Table 16.66 Mergers and Acquisitions: Distribution by Type of Agreement
Table 16.67 Mergers and Acquisitions: Distribution by Key Value Drivers
Table 16.68 Mergers and Acquisitions: Distribution by Year of Acquisition and Key Value Drivers, 2016-2022
Table 16.69 Recent Expansions: Cumulative Year-wise Trend, 2017-2022
Table 16.70 Recent Expansions: Distribution by Type of Expansion
Table 16.71 Recent Expansions: Distribution by Year and Type of Expansion, 2017-2022
Table 16.72 Recent Expansions: Distribution by Type of Product
Table 16.73 Recent Expansions: Distribution by Type of Expansion and Type of Product
Table 16.74 Recent Expansions: Distribution by Area of Expansion
Table 16.75 Most Active Players: Distribution by Number of Expansions
Table 16.76 Recent Expansions: Distribution by Location of Facility (Continent-wise)
Table 16.77 Recent Expansions: Distribution by Location of Facility (Country-wise)
Table 16.78 Recent Expansions: Distribution by Type of Expansion and Location of Facility
Table 16.79 Global Demand for Cell Therapy Consumables for Planar Process, 2023-2035 (Million Liters)
Table 16.80 Global Demand for Cell Therapy Consumables for Suspension Process, 2023-2035 (Million Liters)
Table 16.81 Global Demand for Cell Therapy Consumables for Planar Process, 2023-2035: Distribution by Scale of Operation (Million Liters)
Table 16.82 Global Demand for Cell Therapy Consumables for Suspension Process, 2023-2035: Distribution by Scale of Operation (Million Liters)
Table 16.83 Global Demand for Cell Therapy Consumables: Distribution by Geography, 2023 and 2035
Table 16.84 Global Demand for Cell Therapy Consumables for Planar Process, 2023-2035: Distribution by Geography (Million Liters)
Table 16.85 Global Demand for Cell Therapy Consumables for Suspension Process, 2023-2035: Distribution by Geography (Million Liters)
Table 16.86 Global Cell Therapy Consumables Market, 2023-2035 (USD Million)
Table 16.87 Cell Therapy Consumables Market: Distribution by Type of Product, 2023 and 2035
Table 16.88 Cell Therapy Consumables Market for Extracellular Matrices, 2023-2035 (USD Million)
Table 16.89 Cell Therapy Consumables Market for Kits, 2023-2035 (USD Million)
Table 16.90 Cell Therapy Consumables Market for Media, 2023-2035 (USD Million)
Table 16.91 Cell Therapy Consumables Market for Reagents, 2023-2035 (USD Million)
Table 16.92 Cell Therapy Consumables Market: Distribution by Type of Cell Therapy, 2023, 2028 and 2035
Table 16.93 Cell Therapy Consumables Market for Dendritic Cell Therapies, 2023-2035 (USD Million)
Table 16.94 Cell Therapy Consumables Market for NK Cell Therapies, 2023-2035 (USD Million)
Table 16.95 Cell Therapy Consumables Market for Stem Cell Therapies, 2023-2035 (USD Million)
Table 16.96 Cell Therapy Consumables Market for T-Cell Therapies, 2023-2035 (USD Million)
Table 16.97 Cell Therapy Consumables Market: Distribution by Scale of Operation, 2023 and 2035
Table 16.98 Cell Therapy Consumables Market for Clinical Operations, 2023-2035 (USD Million)
Table 16.99 Cell Therapy Consumables Market for Commercial Operations, 2023-2035 (USD Million)
Table 16.100 Cell Therapy Consumables Market: Distribution by Type of End-User, 2023 and 2035
Table 16.101 Cell Therapy Consumables Market for Industry Players, 2023-2035 (USD Million)
Table 16.102 Cell Therapy Consumables Market for Non-Industry Players, 2023-2035 (USD Million)
Table 16.103 Cell Therapy Consumables Market: Distribution by Geography, 2023 and 2035
Table 16.104 Cell Therapy Consumables Market in North America, 2023-2035 (USD Million)
Table 16.105 Cell Therapy Consumables Market in the US, 2023-2035 (USD Million)
Table 16.106 Cell Therapy Consumables Market in Canada, 2023-2035 (USD Million)
Table 16.107 Cell Therapy Consumables Market in Rest of North America, 2023-2035 (USD Million)
Table 16.108 Cell Therapy Consumables Market in Europe, 2023-2035 (USD Million)
Table 16.109 Cell Therapy Consumables Market in Spain, 2023-2035 (USD Million)
Table 16.110 Cell Therapy Consumables Market in France, 2023-2035 (USD Million)
Table 16.111 Cell Therapy Consumables Market in Germany, 2023-2035 (USD Million)
Table 16.112 Cell Therapy Consumables Market in the UK, 2023-2035 (USD Million)
Table 16.113 Cell Therapy Consumables Market in Italy, 2023-2035 (USD Million)
Table 16.114 Cell Therapy Consumables Market in Netherlands, 2023-2035 (USD Million)
Table 16.115 Cell Therapy Consumables Market in Rest of Europe, 2023-2035 (USD Million)
Table 16.116 Cell Therapy Consumables Market in Asia-Pacific, 2023-2035 (USD Million)
Table 16.117 Cell Therapy Consumables Market in China, 2023-2035 (USD Million)
Table 16.118 Cell Therapy Consumables Market in Japan, 2023-2035 (USD Million)
Table 16.119 Cell Therapy Consumables Market in Rest of Asia-Pacific, 2023-2035 (USD Million)
Table 16.120 Cell Therapy Consumables Market in Middle East and North Africa, 2023-2035 (USD Million)
Table 16.121 Cell Therapy Consumables Market in Latin America, 2023-2035 (USD Million)

List Of Companies

The following companies and organizations have been mentioned in the report:

  1. Accellta
  2. Acer Therapeutics
  3. ACROBiosystems
  4. Activartis Biotech
  5. AddLife
  6. Adicet Bio
  7. Aduro Biotech
  8. Advanced BioMatrix (Acquired by BICO)
  9. Advent Bioservices
  10. AGC Biologics
  11. AgenTus Therapeutics
  12. Agilent Technologies
  13. Ajinomoto
  14. Akadeum Life Sciences
  15. Akron Biotech
  16. Allele Biotechnology and Pharmaceuticals
  17. Allife Medical Science and Technology
  18. Allogene Therapeutics
  19. Altor BioScience
  20. American CryoStem
  21. Amphera
  22. AMSBIO
  23. ANI Pharmaceuticals
  24. apceth Biopharma
  25. Applied Biological Materials
  26. Applied Cells
  27. Arbele
  28. Arcline Investment Management
  29. Argos Therapeutics
  30. Aspire Health Science
  31. Asterias Biotherapeutics
  32. ATCC
  33. Athersys
  34. Atlantis Bioscience
  35. Atreca
  36. Aurora Biopharma
  37. Austrianova
  38. Autolus
  39. Avantor
  40. AVAX Technologies
  41. Axion BioSystems
  42. Axol Bioscience
  43. Basic Pharma
  44. BD Biosciences
  45. Beijing Biohealthcare Biotechnology
  46. Beijing Doing Biomedical
  47. Beijing Immunochina Medical Science & Technology
  48. Beijing Sanwater Biological Technology
  49. Beijing Tricision Biotherapeutics 
  50. Bellicum Pharmaceuticals
  51. Bio Elpida
  52. BioAtla
  53. BioCardia
  54. BioCare
  55. BioCentriq
  56. Bio-Connect
  57. BioInno Bioscience
  58. Bioinova
  59. Biological Industries
  60. BioRestorative Therapies
  61. Bio-Techne 
  62. Biowest
  63. Bone Therapeutics
  64. BrainStorm Cell Therapeutics
  65. Brigham and Women’s Hospital
  66. C3i (Center of Excellence for Cellular Therapy)
  67. Caladrius Biosciences
  68. Capricor Therapeutics
  69. Captain T Cell
  70. Captivate Bio
  71. CardioCell
  72. Carina Biotech
  73. CARsgen Therapeutics
  74. CAR-T (Shanghai) Biotechnology
  75. Cartherics
  76. Celixir
  77. Cell and Gene Therapy Catapult
  78. Cell Applications
  79. Cell Biologics
  80. Cell Biotech
  81. Cell Culture Technologies
  82. Cell Systems
  83. Cell Therapies
  84. Cell-Easy
  85. Cellectis
  86. CellGenix
  87. Cellin Technologies
  88. Cellmed
  89. CellMP (A subsidiary of Emmecell)
  90. CELLnTEC Advanced Cell Systems
  91. CellPraxis
  92. CellProtect Nordic Pharmaceuticals
  93. CellProthera
  94. Cells for Cells 
  95. Cells Online
  96. CellSystems
  97. Cellular Biomedicine Group
  98. Cellular Engineering Technologies
  99. Cellular Therapeutics
  100. Celprogen
  101. Celularity
  102. Celyad
  103. Censo Biotechnologies
  104. CHA Biolab
  105. Chengdu MedGenCell
  106. CiMaas
  107. Cincinnati Children’s Hospital Medical Center
  108. Clean Cells
  109. CO.DON
  110. Cogent Biosciences
  111. Cognate BioServices
  112. CoImmune
  113. CollPlant
  114. Cook MyoSite
  115. Corestem
  116. Corning
  117. Creative Bioarray
  118. Creative Biolabs
  119. CRISPR Therapeutics
  120. Cyagen
  121. Cytiva
  122. Cytopeutics
  123. CytoSen Therapeutics (Acquired by Kiadis Pharma)
  124. Cytovac
  125. CyTuVax 
  126. DanDrit Biotech
  127. DCPrime
  128. Delta-Vir
  129. denovoMATRIX
  130. DiscGenics
  131. ElevateBio
  132. Endocyte
  133. Eureka Therapeutics
  134. Eutilex
  135. EXUMA Biotech
  136. Fate Therapeutics
  137. Fibrocell Technologies
  138. Five Prime Therapeutics
  139. Formula Pharmaceuticals
  140. Fortress Biotech
  141. Froceth
  142. FroggaBio
  143. FUJIFILM Cellular Dynamics
  144. FUJIFILM Wako Pure Chemicals
  145. Gadeta
  146. Gamida Cell
  147. GE Healthcare
  148. GeminiBio
  149. GenCure
  150. GenCure (A subsidiary of BioBridge Global)
  151. GenIbet Biopharmaceuticals
  152. GigaGen 
  153. Global Cell Med
  154. Glycostem Therapeutics
  155. Gradalis
  156. GRI Bio
  157. Guangzhou Trinomab Biotech
  158. Heat Biologics
  159. Hebei Senlang Biotechnology
  160. Hemostemix
  161. HengRui YuanZheng Bio-Technology
  162. HiMedia Laboratories
  163. Histocell
  164. Histogenics
  165. Hitachi Chemical
  166. Holostem Terapie Avanzate
  167. Hunan Zhaotai Yongren Biotech
  168. IBA Lifesciences
  169. iCarTAB BioMed
  170. iCell Gene Therapeutics
  171. Immatics
  172. Immune Therapeutics
  173. Immunicum
  174. ImmunoCellular Therapeutics
  175. Immunovative Therapies 
  176. Immutep
  177. IncoCell Tianjin (A subsidiary of Boyalife)
  178. Incysus
  179. Innoprot
  180. Innovative Cellular Therapeutics
  181. inRegen
  182. International Stem Cell Corporation
  183. InVitria
  184. Iovance Biotherapeutics
  185. Irvine Scientific (Acquired by FUJIFILM)
  186. ISTO Technologies
  187. Ivy Life Sciences
  188. iXCells Biotechnologies
  189. Japan Tissue Engineering
  190. JSR 
  191. JW Biotechnology
  192. JW CreaGene
  193. Kadimastem
  194. Kangstem Biotech
  195. Kiadis Pharma
  196. Kiromic
  197. Kuur Therapeutics
  198. LAgen Laboratories
  199. Laurus Labs
  200. Laurus Bio
  201. Leucid Bio
  202. Life Technologies
  203. Lifecells
  204. Lifeline Cell Technology
  205. Lineage Cell Therapeutics
  206. Lion TCR
  207. Living Pharma
  208. Longeveron
  209. Lonza
  210. Lumos Pharma
  211. Lyell Immunopharma
  212. Lykan Bioscience
  213. Marino Biotechnology
  214. Matrixome
  215. MaxCyte
  216. MBL Beijing Biotech
  217. Medeor Therapeutics
  218. MEDianus Pharma
  219. Medigene
  220. MEDINET
  221. MedVax Technologies
  222. Mesoblast
  223. Metrion Biosciences
  224. Miltenyi Biotech
  225. Minerva Biotechnologies
  226. Minovia Therapeutics
  227. MolecuVax
  228. Moraga Biotechnology
  229. MultiClonal Therapeutics
  230. Multimmune
  231. Multus Biotechnology
  232. Mustang Bio 
  233. Nanjing KAEDI Biotechnology
  234. NantKwest
  235. NeuCyte
  236. Neuralstem
  237. Neuromics
  238. Nikon CeLL innovation
  239. Nkarta
  240. Nohla Therapeutics
  241. Noile-Immune Biotech
  242. Northern Therapeutics
  243. Northwest Biotherapeutics
  244. Novadip Biosciences
  245. NovaRx (Acquired by Viropro)
  246. Novex Innovations
  247. Nucleus Biologics
  248. Nuo Therapeutics
  249. Octapharma
  250. OiDE BetaRevive
  251. Ology Bioservices
  252. Omni Lifesciences
  253. Oncobiomed
  254. Opexa Therapeutics
  255. Orchard Therapeutics
  256. OrganaBio
  257. Ori Biotech
  258. Pall Corporation
  259. PAN-Biotech
  260. PBS Biotech
  261. PDC*line Pharma
  262. PELOBiotech
  263. PeproTech
  264. PersonGen BioTherapeutics
  265. PharmaBio
  266. Pharmicell
  267. PhoenixSongs Biologicals
  268. Pinze Lifetechnology
  269. Pique Therapeutics
  270. Pluristem Therapeutics
  271. Plus Therapeutics
  272. Poseida Therapeutics
  273. Precision BioSciences
  274. Preferred Cell Systems™
  275. Pregene ShenZhen Biotechnology
  276. Primorigen Biosciences (Acquired by Nucleus Biologics)
  277. ProMab Biotechnologies
  278. Promethera Biosciences
  279. PromoCell
  280. Propagenix
  281. Provia Laboratories
  282. R&D Systems
  283. ReachBio Research Labs
  284. Regeneris Medical
  285. Regeneus
  286. ReNeuron
  287. REPROCELL
  288. Rexgenero
  289. RHEACELL
  290. Riyadh Pharma
  291. ROKIT Healthcare
  292. RoosterBio
  293. Roslin Cell Therapies
  294. Rousselot Biomedical
  295. Rubius Therapeutics
  296. S.Biomedics
  297. Sangamo Therapeutics
  298. Sanvitra
  299. Saronic Biotechnology
  300. Sartorius
  301. Sartorius Korea Biotech (A subsidiary of Sartorius)
  302. Sartorius Stedim Biotech
  303. ScienCell Research Laboratories
  304. Scinogy
  305. Sclnow Biotechnology
  306. SCM Lifescience
  307. Sentien Biotechnologies
  308. Shanghai Bioray Laboratory
  309. Shanghai Houchao Biotechnology
  310. Shanghai iCELL Biotechnology
  311. Shanghai Longyao Biotechnology
  312. Shanghai Unicar-Therapy Bio-medicine Technology
  313. Shenzhen BinDeBio
  314. Shenzhen Hornetcorn Biotechnology
  315. Sigma-Aldrich
  316. Sinobioway Cell Therapy
  317. SMT Bio
  318. Sorrento Therapeutics
  319. SQZ Biotechnologies
  320. Stem Cell Arabia
  321. STEMCELL Technologies
  322. StemImmune
  323. Stemmatters 
  324. Super-T Cell Cancer Company
  325. Surface Oncology
  326. Tactiva Therapeutics
  327. Taiwan Bio Therapeutics
  328. Takara Bio
  329. TapImmune 
  330. Targazyme
  331. TC BioPharm
  332. TCR2 Therapeutics
  333. Tella
  334. Tessa Therapeutics
  335. The Discovery Labs Center for Breakthrough Medicines
  336. Thermo Fisher Scientific
  337. ThermoGenesis
  338. Tianhe Stem Cell Biotechnologies
  339. Tianjin Ever Union Biotechnology 
  340. TiGenix
  341. TILT Biotherapeutics
  342. Tmunity Therapeutics
  343. TNK Therapeutics
  344. TotipotentRX
  345. TRACT Therapeutics
  346. TransCure BioServices
  347. TransGen Biotech
  348. TreeFrog Therapeutics
  349. TRINOVA BIOCHEM
  350. Triumvira Immunologics
  351. TVAX Biomedical
  352. U.S. Stem Cell
  353. United States Biological
  354. Universal Cells
  355. Vaccinogen
  356. Vericel
  357. VetStem Biopharma
  358. Vinasets
  359. ViroMed
  360. Viscofan BioEngineering
  361. Vitro Biopharma
  362. Vivo Bio Tech
  363. Waisman Biomanufacturing
  364. West Biotherapy
  365. WiCell
  366. Wissenschaftlicher Service Pharma (WiSP)
  367. Worchester Polytechnic Institute
  368. Wuhan Sian Medical Technology
  369. Xcell Therapeutics
  370. Xcelthera
  371. XEME Biopharma
  372. ZellBio
  373. Zelluna Immunotherapy
  374. Ziopharm Oncology

Source 1: https://www.thermofisher.com/blog/behindthebench/raw-material-considerations-cell-therapy/
Source 2: https://www.cellandgene.com/doc/cell-gene-therapies-investment-outlook-in-beyond-0001

Download Free Sample